SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Telecommunication Products, (TLCR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: leigh aulper who started this subject7/9/2002 12:30:30 PM
From: leigh aulper   of 10
 
Tutogen Medical Expands Senior Management
BUSINESS WIRE - July 09, 2002 10:47
CLIFTON, N.J., Jul 9, 2002 (BW HealthWire) -- Tutogen Medical, Inc. (AMEX: TTG), is pleased to announce the appointments of Mr. Wade Tetsuka, as General Manager of the Tutogen US, and Mr. Erik Boulard as VP of Marketing and Sales, Global Spine Business.

Mr. Tetsuka, 39, will lead in house R&D, product licensing and acquisition, and the commercialization of new bio-implant medical device products. Prior to joining Tutogen, Mr. Tetsuka was a member of August Advisors. He was part of an Executive Management Team focused on medical device and healthcare technologies. Previously, Mr. Tetsuka served as President and CEO of Acoustic Imaging Technologies Corp., a successful diagnostic ultrasound medical technology company. During Mr. Tetsuka's tenure, Acoustic Imaging successfully introduced multiple new products, including new technologies in 3D ultrasound, and established strategic partnerships with several domestic and overseas multinational customers. Mr. Tetsuka's resume also includes stints as Vice President and Controller for Dornier MedTech in Munich, Germany, and for Fairchild Technologies in Germany and France.

Mr. Erik Boulard, 40, has more than 12 years of European surgical sales and marketing experience. He joined Tutogen in June 1999, as General Manager and successfully launched Tutogen France in Paris. He was responsible for regulatory, sales, marketing, finance and administration. Under Mr. Boulard's leadership, Tutogen took the #2 position in the French allograft market. Mr. Boulard will be responsible for launching new products for the Global spine markets. Prior to joining Tutogen, Mr. Boulard held executive level positions at Stryker France S.A.; Scient'X; and Biotrol Laboratories.

"With these additions to our senior management team, we gain two proven exceptional business leaders with a wealth of experience in the international medical products and services industry," commented Mr. Manfred K. Krueger, Tutogen President and CEO. Their sales and management skills will help guide our growth as we continue to expand in domestic and global markets."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext